Literature DB >> 7326555

Persistence of miconazole in vaginal secretions after single applications. Implications for the treatment of vaginal candidosis.

F C Odds, F MacDonald.   

Abstract

In vaginal secretions from 16 healthy women aged between 20 and 27 years miconazole persisted in biodetectable concentrations for at least 48 hours after insertion of a single miconazole vaginal pessary. This finding casts doubt on cure rates in vaginal candidosis determined soon after the end of treatment and suggests that current treatment courses with imidazole antifungal agents may be longer than their nominal three or five days.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7326555      PMCID: PMC1045984          DOI: 10.1136/sti.57.6.400

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  3 in total

1.  Three-day clotrimazole treatment in candidal vulvovaginitis.

Authors:  G Masterton; I R Napier; J N Henderson; J E Roberts
Journal:  Br J Vener Dis       Date:  1977-04

Review 2.  Recent developments in antimycotic chemotherapy.

Authors:  R J Holt
Journal:  Infection       Date:  1974       Impact factor: 3.553

3.  Yeast vaginitis. Nystatin vs monistat in treatment of vaginal candidiasis.

Authors:  W J Cameron
Journal:  J Kans Med Soc       Date:  1978-07
  3 in total
  3 in total

Review 1.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

2.  Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical use.

Authors:  E Lefler; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.